HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ocular response of choroidal melanoma with monosomy 3 versus disomy 3 after iodine-125 brachytherapy.

AbstractPURPOSE:
To report the ocular response of choroidal melanoma with monosomy 3 vs. disomy 3 after (125)I brachytherapy.
METHODS AND MATERIALS:
We evaluated patients with ciliochoroidal melanoma managed with fine needle aspiration biopsy immediately before plaque application for (125)I brachytherapy between January 1, 2005 and December 31, 2008. Patients with (1) cytopathologic diagnosis of melanoma, (2) melanoma chromosome 3 status identified by fluorescence in situ hybridization, and (3) 6 or more months of follow-up after brachytherapy were sorted by monosomy 3 vs. disomy 3 and compared by Kruskal-Wallis test.
RESULTS:
Among 40 ciliochoroidal melanomas (40 patients), 15 had monosomy 3 and 25 had disomy 3. Monosomy 3 melanomas had a median greatest basal diameter of 12.00 mm and a median tumor thickness of 6.69 mm before brachytherapy; at a median of 1.75 years after brachytherapy, median thickness was 3.10 mm. Median percentage decrease in tumor thickness was 48.3%. Disomy 3 melanomas had a median greatest basal diameter of 10.00 mm and median tumor thickness of 3.19 mm before brachytherapy; at a median of 2.00 years after brachytherapy, median tumor thickness was 2.37 mm. The median percentage decrease in tumor thickness was 22.7%. Monosomy 3 melanomas were statistically greater in size than disomy 3 melanomas (p < 0.001) and showed a greater decrease in tumor thickness after brachytherapy (p = 0.006).
CONCLUSION:
In this study, ciliochoroidal melanomas with monosomy 3 were significantly greater in size than disomy 3 melanoma and showed a significantly greater decrease in thickness at a median of 1.75 years after brachytherapy. The greater decrease in monosomy 3 melanoma thickness after brachytherapy is consistent with other malignancies in which more aggressive pathology has been shown to be associated with a greater initial response to radiotherapy.
AuthorsOmkar S Marathe, Jeffrey Wu, Steve P Lee, Fei Yu, Barry L Burgess, Min Leu, Bradley R Straatsma, Tara A McCannel
JournalInternational journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys) Vol. 81 Issue 4 Pg. 1046-8 (Nov 15 2011) ISSN: 1879-355X [Electronic] United States
PMID20932685 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Iodine Radioisotopes
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biopsy, Fine-Needle (methods)
  • Brachytherapy (methods)
  • Choroid (pathology)
  • Choroid Neoplasms (genetics, pathology, radiotherapy)
  • Chromosomes, Human, Pair 3 (genetics)
  • Ciliary Body (pathology)
  • Humans
  • Iodine Radioisotopes (therapeutic use)
  • Melanoma (genetics, pathology, radiotherapy)
  • Middle Aged
  • Monosomy
  • Nondisjunction, Genetic
  • Retrospective Studies
  • Statistics, Nonparametric
  • Time Factors
  • Tumor Burden (radiation effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: